Check out this quick case study about tackling timelines.
Quick Case Study:
First EMA Approval
Idem partnered with a mid-size biopharmaceutical company working through their first EMA centralized procedure. By building a two-part timeline and scheduling resources in advance, the required EMA translations were completed and submitted on the very tight procedural timetable. As a result, the company’s therapy was approved for use in all 28 EU countries, as well as in Norway, Iceland, and Liechtenstein.
Efficiency Buys You Flexibility
Together, we can slow the clock by planning ahead.
Translations are often late in the product workflow, but a forward-thinking provider can keep you ahead of the game.
